{"id":711,"date":"2012-03-23T22:04:36","date_gmt":"2012-03-23T22:04:36","guid":{"rendered":"http:\/\/www.symphonytg.com\/?p=711"},"modified":"2012-03-23T22:04:36","modified_gmt":"2012-03-23T22:04:36","slug":"impactrx-acquires-alphadetail","status":"publish","type":"post","link":"https:\/\/stg.com\/news\/impactrx-acquires-alphadetail\/","title":{"rendered":"Impactrx Acquires Alphadetail"},"content":{"rendered":"<p><em>addition of AlphaDetail\u2019s global custom market research expertise enhances and expands company\u2019s solutions offerings<br \/>\n<\/em><\/p>\n<p><p>\nHorsham, PA \u2013 March 23, 2012 &#8211; ImpactRx, a Symphony Technology Group (STG) company, and the pioneer in measuring the impact of promotion on physicians\u2019 attitudes and prescribing behavior, announced today that it has acquired AlphaDetail, Inc., a leader in global healthcare primary market research and influence network mapping. AlphaDetail was recently named one of the top fifty US market research firms in the annual Honomichl survey.  Financial terms of the transaction were not disclosed.<\/p>\n<p>AlphaDetail will be closely integrated across ImpactRx\u2019s operations, but will maintain its name and branding and will operate as the custom market research unit of the company.  AlphaDetail\u2019s existing management team will continue to lead the unit and Rishi Varma, AlphaDetail\u2019s current CEO, will also become Executive Vice President, Custom Market Research, ImpactRx and will report to ImpactRx President and CEO, Gregory Ellis.<\/p>\n<p>\u201cWe are very excited to add AlphaDetail\u2019s custom research expertise and consultative approach to ImpactRx\u2019s broad portfolio of promotional effectiveness and consulting analytics solutions,\u201d declared Ellis.  \u201cAlphaDetail\u2019s deep understanding of client needs and exceptional analytical talent will enable ImpactRx to provide incremental value to our clients,\u201d Ellis stated.  \u201cFor example, clients\u2019 product forecasting needs will be better served by integrating AlphaDetail\u2019s trusted ability to develop and conduct actionable research with ImpactRx\u2019s data assets and capabilities,\u201d concluded Ellis.<\/p>\n<p>\u201cWe are thrilled to join ImpactRx at this stage in the company\u2019s development,\u201d said Rishi Varma, AlphaDetail\u2019s CEO.  \u201cSince AlphaDetail\u2019s inception eleven years ago, we have focused on building our business through an unparalleled commitment to our clients and to execution excellence,\u201d Varma continued.  \u201cWe\u2019re eager to begin integrating this focus and our skill set with ImpactRx\u2019s unique research model and world-class data and analytical assets to deliver even more value to our combined customer base,\u201d concluded Varma.<\/p>\n<p>\u201cOur strategic intent when we acquired ImpactRx almost one year ago was to build a differentiated solutions company in life sciences capable of delivering compelling value through insights informed by data,\u201d said J.T. Treadwell, Managing Director with STG.  \u201cAlphaDetail is a great organization with a reputation for quality work and highly satisfied customers, as is ImpactRx.  The addition of AlphaDetail\u2019s strong global custom research expertise, analytical skill and therapeutic knowledge to ImpactRx\u2019s innovative and extensive promotional effectiveness capabilities will enable us to significantly broaden our footprint as a best-in-class solutions provider,\u201d Treadwell stated.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>addition of AlphaDetail\u2019s global custom market research expertise enhances and expands company\u2019s solutions offerings Horsham, PA \u2013 March 23, 2012 &#8211; ImpactRx, a Symphony Technology Group (STG) company, and the pioneer in measuring the impact of promotion on physicians\u2019 attitudes and prescribing behavior, announced today that it has acquired AlphaDetail, Inc., a leader in global&hellip;<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"node_moved":[],"footnotes":""},"categories":[6],"tags":[],"company":[],"class_list":["post-711","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"acf":[],"yoast_head":"\n<title>Impactrx Acquires Alphadetail - STG<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/stg.com\/news\/impactrx-acquires-alphadetail\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Impactrx Acquires Alphadetail - STG\" \/>\n<meta property=\"og:description\" content=\"addition of AlphaDetail\u2019s global custom market research expertise enhances and expands company\u2019s solutions offerings Horsham, PA \u2013 March 23, 2012 &#8211; ImpactRx, a Symphony Technology Group (STG) company, and the pioneer in measuring the impact of promotion on physicians\u2019 attitudes and prescribing behavior, announced today that it has acquired AlphaDetail, Inc., a leader in global&hellip;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/stg.com\/news\/impactrx-acquires-alphadetail\/\" \/>\n<meta property=\"og:site_name\" content=\"STG\" \/>\n<meta property=\"article:published_time\" content=\"2012-03-23T22:04:36+00:00\" \/>\n<meta name=\"author\" content=\"Gloria Consola\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Gloria Consola\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/stg.com\/news\/impactrx-acquires-alphadetail\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/stg.com\/news\/impactrx-acquires-alphadetail\/\"},\"author\":{\"name\":\"Gloria Consola\",\"@id\":\"https:\/\/stg.com\/#\/schema\/person\/d2ea413311d661450e19c0e000a9be8b\"},\"headline\":\"Impactrx Acquires Alphadetail\",\"datePublished\":\"2012-03-23T22:04:36+00:00\",\"dateModified\":\"2012-03-23T22:04:36+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/stg.com\/news\/impactrx-acquires-alphadetail\/\"},\"wordCount\":418,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/stg.com\/#organization\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/stg.com\/news\/impactrx-acquires-alphadetail\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/stg.com\/news\/impactrx-acquires-alphadetail\/\",\"url\":\"https:\/\/stg.com\/news\/impactrx-acquires-alphadetail\/\",\"name\":\"Impactrx Acquires Alphadetail - STG\",\"isPartOf\":{\"@id\":\"https:\/\/stg.com\/#website\"},\"datePublished\":\"2012-03-23T22:04:36+00:00\",\"dateModified\":\"2012-03-23T22:04:36+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/stg.com\/news\/impactrx-acquires-alphadetail\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/stg.com\/news\/impactrx-acquires-alphadetail\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/stg.com\/news\/impactrx-acquires-alphadetail\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/stg.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Impactrx Acquires Alphadetail\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/stg.com\/#website\",\"url\":\"https:\/\/stg.com\/\",\"name\":\"STG\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/stg.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/stg.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/stg.com\/#organization\",\"name\":\"STG Partners, LLC\",\"url\":\"https:\/\/stg.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/stg.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/stg.com\/wp-content\/uploads\/2022\/03\/stg-logo-footer.svg\",\"contentUrl\":\"https:\/\/stg.com\/wp-content\/uploads\/2022\/03\/stg-logo-footer.svg\",\"width\":283,\"height\":132,\"caption\":\"STG Partners, LLC\"},\"image\":{\"@id\":\"https:\/\/stg.com\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/stg.com\/#\/schema\/person\/d2ea413311d661450e19c0e000a9be8b\",\"name\":\"Gloria Consola\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/stg.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/8f8b12d3166df48670d5c104f7739953?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/8f8b12d3166df48670d5c104f7739953?s=96&d=mm&r=g\",\"caption\":\"Gloria Consola\"}}]}<\/script>\n","yoast_head_json":{"title":"Impactrx Acquires Alphadetail - STG","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/stg.com\/news\/impactrx-acquires-alphadetail\/","og_locale":"en_US","og_type":"article","og_title":"Impactrx Acquires Alphadetail - STG","og_description":"addition of AlphaDetail\u2019s global custom market research expertise enhances and expands company\u2019s solutions offerings Horsham, PA \u2013 March 23, 2012 &#8211; ImpactRx, a Symphony Technology Group (STG) company, and the pioneer in measuring the impact of promotion on physicians\u2019 attitudes and prescribing behavior, announced today that it has acquired AlphaDetail, Inc., a leader in global&hellip;","og_url":"https:\/\/stg.com\/news\/impactrx-acquires-alphadetail\/","og_site_name":"STG","article_published_time":"2012-03-23T22:04:36+00:00","author":"Gloria Consola","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Gloria Consola","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/stg.com\/news\/impactrx-acquires-alphadetail\/#article","isPartOf":{"@id":"https:\/\/stg.com\/news\/impactrx-acquires-alphadetail\/"},"author":{"name":"Gloria Consola","@id":"https:\/\/stg.com\/#\/schema\/person\/d2ea413311d661450e19c0e000a9be8b"},"headline":"Impactrx Acquires Alphadetail","datePublished":"2012-03-23T22:04:36+00:00","dateModified":"2012-03-23T22:04:36+00:00","mainEntityOfPage":{"@id":"https:\/\/stg.com\/news\/impactrx-acquires-alphadetail\/"},"wordCount":418,"commentCount":0,"publisher":{"@id":"https:\/\/stg.com\/#organization"},"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/stg.com\/news\/impactrx-acquires-alphadetail\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/stg.com\/news\/impactrx-acquires-alphadetail\/","url":"https:\/\/stg.com\/news\/impactrx-acquires-alphadetail\/","name":"Impactrx Acquires Alphadetail - STG","isPartOf":{"@id":"https:\/\/stg.com\/#website"},"datePublished":"2012-03-23T22:04:36+00:00","dateModified":"2012-03-23T22:04:36+00:00","breadcrumb":{"@id":"https:\/\/stg.com\/news\/impactrx-acquires-alphadetail\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/stg.com\/news\/impactrx-acquires-alphadetail\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/stg.com\/news\/impactrx-acquires-alphadetail\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/stg.com\/"},{"@type":"ListItem","position":2,"name":"Impactrx Acquires Alphadetail"}]},{"@type":"WebSite","@id":"https:\/\/stg.com\/#website","url":"https:\/\/stg.com\/","name":"STG","description":"","publisher":{"@id":"https:\/\/stg.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/stg.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/stg.com\/#organization","name":"STG Partners, LLC","url":"https:\/\/stg.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/stg.com\/#\/schema\/logo\/image\/","url":"https:\/\/stg.com\/wp-content\/uploads\/2022\/03\/stg-logo-footer.svg","contentUrl":"https:\/\/stg.com\/wp-content\/uploads\/2022\/03\/stg-logo-footer.svg","width":283,"height":132,"caption":"STG Partners, LLC"},"image":{"@id":"https:\/\/stg.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/stg.com\/#\/schema\/person\/d2ea413311d661450e19c0e000a9be8b","name":"Gloria Consola","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/stg.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/8f8b12d3166df48670d5c104f7739953?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/8f8b12d3166df48670d5c104f7739953?s=96&d=mm&r=g","caption":"Gloria Consola"}}]}},"_links":{"self":[{"href":"https:\/\/stg.com\/wp-json\/wp\/v2\/posts\/711"}],"collection":[{"href":"https:\/\/stg.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stg.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stg.com\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/stg.com\/wp-json\/wp\/v2\/comments?post=711"}],"version-history":[{"count":0,"href":"https:\/\/stg.com\/wp-json\/wp\/v2\/posts\/711\/revisions"}],"wp:attachment":[{"href":"https:\/\/stg.com\/wp-json\/wp\/v2\/media?parent=711"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stg.com\/wp-json\/wp\/v2\/categories?post=711"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stg.com\/wp-json\/wp\/v2\/tags?post=711"},{"taxonomy":"company","embeddable":true,"href":"https:\/\/stg.com\/wp-json\/wp\/v2\/company?post=711"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}